ALNYLAM PHARMACEUTICALS, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Alnylam Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Alnylam Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$112M, a 176% decline year-over-year.
  • Alnylam Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$332M, a 34.8% increase year-over-year.
  • Alnylam Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$440M, a 61.1% increase from 2022.
  • Alnylam Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$1.13B, a 32.6% decline from 2021.
  • Alnylam Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$853M, a 0.64% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$440M +$691M +61.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 -$1.13B -$278M -32.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 -$853M +$5.46M +0.64% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 -$858M +$27.8M +3.14% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$886M -$125M -16.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-10
2018 -$761M -$271M -55.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 -$491M -$80.8M -19.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 -$410M -$120M -41.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
2015 -$290M +$70.3M +19.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-15
2014 -$360M -$271M -304% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-15
2013 -$89.2M +$16.8M +15.8% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-12
2012 -$106M -$48.4M -83.9% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-13
2011 -$57.6M -$14.1M -32.5% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-20
2010 -$43.5M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.